Physician profile
Burke E Thompson
NPI 1457336778
$6,207.19
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,424 · 2020: $186 · 2021: $78.90 · 2022: $288 · 2023: $153 · 2024: $76.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $5,288.32 | 2019 | |
| Haemonetics Corporation | $276.97 | 2020-2024 | Teg6s Hemostasis System |
| Merck Sharp & Dohme LLC | $72.92 | 2020-2023 | Keytruda |
| Innocoll Pharmaceuticals Limited | $55.97 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Heron Therapeutics, INC. | $50.93 | 2022 | |
| Smith+Nephew, INC. | $44.39 | 2020-2022 | |
| Ethicon US, LLC | $40.32 | 2020 | |
| Kerecis Limited | $35.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Pacira Pharmaceuticals Incorporated | $26.12 | 2019 | |
| Atricure, INC. | $25.29 | 2019 | |
| Rti Surgical, INC | $24.86 | 2023 | |
| Edwards Lifesciences Corporation | $24.41 | 2023 | Hemosphere |
| Medtronic, INC. | $20.72 | 2023 | Emprint |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioptics, INC. | $19.09 | 2019 | |
| Csl Behring | $18.54 | 2019 | |
| Davol INC. | $18.50 | 2022 | |
| Abbvie INC. | $17.40 | 2020 | |
| Covidien LP | $17.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.10 | 2023 | Andexxa |
| Checkpoint Surgical, INC | $16.32 | 2019 | |
| Shire North American Group INC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burke Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.